Mg OSTEOCRETE Post-Treatment Outcomes
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand th
| Condition(s) | Cancer of Bone, Trauma, Aseptic Loosening of Orthopaedic Hardware |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes. |
| Who can participate | Inclusion Criteria: * 18 years of age and older on the day of surgery * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product * Mg OSTEOCRETE is indicated for one of the following reasons: 1. as a bone void filler following bone tumor resection, or; 2. as an augment for defects causing aseptic loosening of orthopaedic implants, or; 3. to help substitute bone for trauma-related conditions Exclusion Criteria: * any contraindication as per Instructions for Use for Mg OSTEOCRETE |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Santiago Lozano-Calderon |
| Locations | Boston, Massachusetts, United States |
| Start date | 2025-03-17 |
| NCT ID | NCT06720142 |
| Official listing | https://clinicaltrials.gov/study/NCT06720142 |